Research Article
Safety and Efficacy of Nonanesthesiologist-Administrated Propofol during Endoscopic Submucosal Dissection of Gastric Epithelial Tumors
Table 3
Adverse events related to propofol.
| | ASA 1 | ASA 2 | ASA 3 | Total | value |
| | Propofol-related complications (n (%)) | | At induction of bolus injection | | Hypotension | 9 (4.94) | 22 (8.06) | 8 (11.9) | 39 (7.47) | 0.154 | | Desaturation | 78 (42.8) | 139 (50.9) | 36 (53.7) | 253 (48.4) | 0.158 | | Bradycardia | 3 (1.64) | 8 (2.93) | 4 (5.97) | 15 (2.87) | 0.194 | | During maintenance infusion | | Hypotension | 17 (9.34) | 41 (15.0) | 13 (19.4) | 71 (13.6) | 0.075 | | Desaturation | 5 (2.74) | 4 (1.47) | 2 (2.98) | 11 (2.11) | 0.561 | | Bradycardia | 5 (2.74) | 11 (4.02) | 3 (4.47) | 19 (3.63) | 0.717 | | Resedated condition | | Hypotension | 0 (0) | 2 (0.73) | 1 (1.49) | 3 (0.57) | 0.340 | | Desaturation | 0 (0) | 1 (0.37) | 0 (0) | 1 (0.19) | 0.634 | | Bradycardia | 1 (0.55) | 3 (1.09) | 1 (1.49) | 5 (0.95) | 0.749 |
|
|
